Sign up to save your podcasts
Or
Share How Many Metastases Rule Out Ablation?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How Many Metastases Rule Out Ablation?
Dr. David Kerr reports on a study fueling the controversy about which CRC patients with unresectable liver mets who receive conversion chemotherapy are candidates for secondary resection or ablation.
View all episodes
By MedscapeDr. David Kerr reports on a study fueling the controversy about which CRC patients with unresectable liver mets who receive conversion chemotherapy are candidates for secondary resection or ablation.